Cargando…
New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs
Bladder cancer is a worldwide problem and improved therapies are urgently needed. In the search for newer strong antitumor compounds, herein, we present the study of three nitric oxide-releasing compounds and evaluate them as possible therapies for this malignancy. Bladder cancer cell lines T24 and...
Autores principales: | Varela, María, López, Miriam, Ingold, Mariana, Alem, Diego, Perini, Valentina, Perelmuter, Karen, Bollati-Fogolín, Mariela, López, Gloria V., Hernández, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855963/ https://www.ncbi.nlm.nih.gov/pubmed/36672707 http://dx.doi.org/10.3390/biomedicines11010199 |
Ejemplares similares
-
Generation and Characterization of Stable Redox-Reporter Mammalian Cell Lines of Biotechnological Relevance
por: Perelmuter, Karen, et al.
Publicado: (2022) -
HT-29 and Caco-2 Reporter Cell Lines for Functional Studies of Nuclear Factor Kappa B Activation
por: Mastropietro, Giuliana, et al.
Publicado: (2015) -
Progress and Promise of Nitric Oxide‐Releasing Platforms
por: Yang, Tao, et al.
Publicado: (2018) -
Modeling the human placental barrier to understand Toxoplasma gondii´s vertical transmission
por: Faral-Tello, Paula, et al.
Publicado: (2023) -
Jejunum-derived NF-κB reporter organoids as 3D models for the study of TNF-alpha-induced inflammation
por: Daghero, Hellen, et al.
Publicado: (2022)